Clinical Utility of Preoperative Thyroid GuidePx® Testing
NCT07584447 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 85
Last updated 2026-06-01
Summary
The purpose of this study is to learn whether having Thyroid GuidePx® test results available before treatment may help patients with papillary thyroid cancer and doctors make better-informed treatment decisions.
Conditions
- Papillary Thyroid Cancer
- Papillary Thyroid Carcinoma
Sponsors & Collaborators
-
Qualisure Diagnostics Inc.
collaborator UNKNOWN -
University of Alberta
collaborator OTHER -
University of Calgary
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2028-04-30
- Completion
- 2029-04-30
More Related Trials
-
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
NCT03757637 ·Status: RECRUITING ·Phase: NA
-
CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer
NCT03359668 ·Status: COMPLETED ·Phase: NA
-
Changes in Metabolic Status in Patients With Total Thyroidectomy
NCT01781767 ·Status: UNKNOWN
-
Treatment for Patients With Metastatic Thyroid Cancer
NCT00176748 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging
NCT03470259 ·Status: COMPLETED ·Phase: PHASE1
-
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
NCT01149161 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer
NCT01083550 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3
NCT03488134 ·Status: COMPLETED
-
An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules
NCT01307761 ·Status: UNKNOWN
-
Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
NCT03300284 ·Status: COMPLETED
-
Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology
NCT02225509 ·Status: UNKNOWN ·Phase: NA
-
Leptin Levels in Papillary Thyroid Cancer
NCT01659385 ·Status: COMPLETED
-
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
NCT00094055 ·Status: COMPLETED ·Phase: PHASE2
-
Active Surveillance of Papillary Thyroid Microcarcinoma
NCT02609685 ·Status: RECRUITING ·Phase: NA
-
The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
NCT01792492 ·Status: COMPLETED
-
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
NCT06073223 ·Status: COMPLETED ·Phase: NA
-
APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.
NCT02323724 ·Status: COMPLETED
-
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
NCT06325787 ·Status: COMPLETED ·Phase: NA
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
NCT07354698 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW
NCT06095362 ·Status: COMPLETED ·Phase: PHASE1
-
Circulating Biomarkers to Identify Thyroid Cancer
NCT04594720 ·Status: COMPLETED
-
The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study.
NCT02602717 ·Status: UNKNOWN ·Phase: NA
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
NCT03032198 ·Status: TERMINATED ·Phase: NA